Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 07.09.2026 FBTU.LN IE00BL0L0H60  500,002.00 USD  16,583,417.94   33.167  ...
-

DC BLOX Launches Community Commitment to Formalize Its Pledge to the Neighborhoods Where It Builds

ATLANTA--(BUSINESS WIRE)--DC BLOX, a leading provider of connected data center and fiber network solutions across the Southeastern United States, today announced the launch of the DC BLOX Community Commitment, a formal pledge outlining the company's responsibilities to the communities where it develops and operates digital infrastructure. The Community Commitment codifies ten foundational pillars, including power and grid enhancement, water conservation, sound management, air quality, responsib...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx NextG UCITS ETF 07.09.2026 NXTG.LN IE00BWTNM743  170,002.00 USD   9,676,887.30   56.922  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Capital Strength UCITS ETF 07.09.2026 FTCS. IE00BL0L0D23  225,002.00 USD   7,811,361.77   34.717  ...
-

Encoded Therapeutics Presents Updated Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the 16th European Epilepsy Congress

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Presents Updated Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the European Epilepsy Congress....
-

Endeavor BioMedicines Presents New Quantitative Imaging Data from Analysis of Phase 2a Clinical Trial Evaluating Taladegib (ENV-101) in Patients with Idiopathic Pulmonary Fibrosis

SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today presented a quantitative imaging post hoc analysis from its Phase 2a trial evaluating its investigational therapy taladegib (ENV-101) in individuals with idiopathic pulmonary fibrosis (IPF). Results demonstrated significant improvement in lung volume, as well...
-

Vital Capital Partners Completes $9.67 Million Raise for Dallas Pediatric Hospital DST

DALLAS--(BUSINESS WIRE)--Vital Capital Partners, a healthcare real estate investment manager, announced today the full subscription of a $9.67 million private placement offering, HPA Exchange – Vital Medical Dallas TX DST, through the independent broker-dealer and registered investment advisor network. Vital Capital Partners sponsored the offering through a joint venture. This marks the third medical Delaware statutory trust offering the firm has fully subscribed since entering the private wealt...
-

Applied BioCode Announces Distribution Agreement with Henry Schein

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode today announced a distribution agreement with Henry Schein, a leading provider of healthcare products and services, to expand the availability of its BioCode® MDx-3000 System and comprehensive molecular diagnostics menu. The BioCode® MDx-3000 is an automated, high-throughput multiplex molecular diagnostic platform designed to support high-complexity clinical laboratories. Its testing menu includes upper respiratory and gastrointestinal...
-

ONE Nuclear Advances 1 GW SMR Project within its Louisiana Development Platform

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--ONE Nuclear Energy LLC ("ONE Nuclear"), an independent developer of large-scale energy solutions powered by natural gas and advanced nuclear technologies, announced today that it is advancing Project Amberjack, a small modular reactor (“SMR”) project in Louisiana, into technical and environmental evaluation. This follows the company’s announcement last week of a separate 2.88 GW energy project in Louisiana, entitled Project Cayman. Project Amberjack is be...
-

Dealership Buy/Sell Market Soars as Auto Dealership Groups Scale Up

INCLINE VILLAGE, Nev.--(BUSINESS WIRE)--The auto dealership buy/sell market extended its record run in the first half of 2026, with 224 transactions completed through June and a record 462 buy/sells in the trailing twelve months, exceeding 2025’s record of 458, according to the just-released Second Quarter 2026 Blue Sky Report® by Kerrigan Advisors, the industry authority on the dealership buy/sell market and valuation trends distributed to over 17,000 industry participants in 35 countries. The...